Jose Lutzky
- Oncology top 0.5%
- CAR-T cell therapy research 49
- Cancer Immunotherapy and Biomarkers 46
- Cutaneous Melanoma Detection and Management 12
- Immunology top 1%
- Immunotherapy and Immune Responses 36
- Hematology top 2%
- Molecular Biology top 5%
- Melanoma and MAPK Pathways 20
- Biological Psychiatry top 10%
-
- Virus-based gene therapy research 14
-
- Monoclonal and Polyclonal Antibodies Research 12
-
- Cancer Research and Treatments 12
- Co-authors
- Axel HoosGerald P. LinetteSteven O’DayJedd D. WolchokCélèste LebbéJason ChesneyBart NeynsSylvie Négrier
- Cited by
- OncologyImmunologyHematology
- Journals
- Nature Communications (2 papers)Journal of Clinical Oncology (57 papers)SHILAP Revista de lepidopterología (3 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Jose Lutzky
128 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 3.5k
- Immunology 1.9k
- Hematology 544
- Molecular Biology 1.9k
- Biological Psychiatry 63
Countries citing papers authored by Jose Lutzky
This map shows the geographic impact of Jose Lutzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jose Lutzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jose Lutzky more than expected).
Fields of papers citing papers by Jose Lutzky
This network shows the impact of papers produced by Jose Lutzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jose Lutzky. The network helps show where Jose Lutzky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jose Lutzky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 136 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 60 | |
| 11 | 2018 | 13 | |
| 12 | 2016 | 7 | |
| 13 | 2015 | 97 | |
| 14 | 2013 | 10 | |
| 15 | 2011 | 93 | |
| 16 | Clinical response to ipilimumab: Effect of systemic corticosteroids used to manage immune-related adverse events (irAEs) | 2010 | 5 |
| 17 | 2009 | 37 | |
| 18 | 2006 | 64 | |
| 19 | 2005 | 28 | |
| 20 | Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-mediated reduction of glutathione levels and cytotoxicity in normal and leukemic bone marrow progenitor cells. | 1992 | 5 |
About Jose Lutzky
Jose Lutzky is a scholar working on Oncology, Immunology and Hematology, having authored 133 papers that have together received 4.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (49 papers), Cancer Immunotherapy and Biomarkers (46 papers), Immunotherapy and Immune Responses (36 papers), Melanoma and MAPK Pathways (20 papers), Virus-based gene therapy research (14 papers), Cutaneous Melanoma Detection and Management (12 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Cancer Research and Treatments (12 papers). The work is most often cited by research in Oncology (3.5k citations), Immunology (1.9k citations) and Hematology (544 citations). Jose Lutzky has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Axel Hoos, Gerald P. Linette, Steven O’Day, Jedd D. Wolchok, Célèste Lebbé, Jason Chesney, Bart Neyns, Sylvie Négrier, L. Thomas and William Waterfield. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.